Data / Drug companies / McKesson Corporation DBA Sky Packaging
McKesson Corporation DBA Sky Packaging: 21 products in the FDA NDC directory, labeler code 63739
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
McKesson Corporation DBA Sky Packaging (labeler code 63739) lists 21 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 18 prescription drugs, 3 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 27, 2024.
The request: Watch McKesson Corporation DBA Sky Packaging (FDA labeler code 63739): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63739
- Products in commercial distribution
- 21
- Packages
- 14
- Finished drugs by generic name
- 8
- Prescription products
- 18
- Over the counter products
- 3
- Flagged as original packager
- 19 of 19 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 7
- Earliest marketing start
- August 22, 2007
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 18 | 85.7% |
| Over the counter drugs | 3 | 14.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Heparin sodium | 9 | 23 |
| Gabapentin | 3 | 91 |
| Mirtazapine | 2 | 42 |
| Lidocaine hydrochloride | 2 | 134 |
| Nicotine polacrilex | 2 | 57 |
| Clopidogrel bisulfate | 1 | 31 |
| Chlorhexidine gluconate | 1 | 34 |
| Guaifenesin | 1 | 123 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 9 | 42.9% |
| Capsule | 3 | 14.3% |
| Tablet, film coated | 3 | 14.3% |
| Solution | 2 | 9.5% |
| Gum, chewing | 2 | 9.5% |
| Rinse | 1 | 4.8% |
| Tablet, extended release | 1 | 4.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Anti-coagulant | 9 |
| Unfractionated Heparin | 9 |
| Amide Local Anesthetic | 2 |
| Antiarrhythmic | 2 |
| Cholinergic Nicotinic Agonist | 2 |
| P2Y12 Platelet Inhibitor | 1 |
| Expectorant | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lidocaine Hydrochloride | 63739-997 | Solution | Generic drugs (ANDA) | June 27, 2024 |
| Clopidogrel bisulfate | 63739-178 | Tablet, film coated | Generic drugs (ANDA) | August 18, 2022 |
| Lidocaine Hydrochloride | 63739-170 | Solution | Generic drugs (ANDA) | June 22, 2022 |
| Mucus Relief | 63739-067 | Tablet, extended release | Generic drugs (ANDA) | October 20, 2021 |
| Gabapentin | 63739-904 | Capsule | Generic drugs (ANDA) | July 15, 2021 |
| Gabapentin | 63739-903 | Capsule | Generic drugs (ANDA) | July 15, 2021 |
| Gabapentin | 63739-902 | Capsule | Generic drugs (ANDA) | July 15, 2021 |
| Sky Oral Rinse | 63739-052 | Rinse | Generic drugs (ANDA) | December 1, 2020 |
| Nicotine | 63739-371 | Gum, chewing | Generic drugs (ANDA) | April 27, 2020 |
| Nicotine | 63739-369 | Gum, chewing | Generic drugs (ANDA) | April 27, 2020 |
| Heparin Sodium | 63739-986 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-975 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-964 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-953 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-942 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-931 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-920 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-901 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Heparin Sodium | 63739-900 | Injection, solution | Generic drugs (ANDA) | June 12, 2014 |
| Mirtazapine | 63739-099 | Tablet, film coated | Generic drugs (ANDA) | August 22, 2007 |
| Mirtazapine | 63739-098 | Tablet, film coated | Generic drugs (ANDA) | August 22, 2007 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.